Vasopressin stimulates the production of extracellular matrix by cultured rat mesangial cells

Clinical and Experimental Pharmacology and Physiology

Volumn 35, Issue 5-6, 2008, Pages 586-593

  Tahara, Atsuo ^a   Tsukada, Junko ^a   Tomura, Yuichi ^a   Suzuki, Takeshi ^a   Yatsu, Takeyuki ^a   Shibasaki, Masayuki ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

Extracellular matrix; Mesangial cells; V1A receptors; Vasopressin; YM218

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 4; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR ANTAGONIST; FIBRONECTIN; GELATINASE A; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; SATAVAPTAN; SCLEROPROTEIN; UNCLASSIFIED DRUG; VASOPRESSIN; VASOPRESSIN RECEPTOR ANTAGONIST; VASOPRESSIN V1A RECEPTOR; VASOPRESSIN V2 RECEPTOR; YM 218;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONCENTRATION RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; GLOMERULOPATHY; MALE; MESANGIUM; NONHUMAN; PROTEIN DEGRADATION; PROTEIN SECRETION; PROTEIN SYNTHESIS INHIBITION; RAT;

ANIMALS; ARGININE VASOPRESSIN; COLLAGEN TYPE I; COLLAGEN TYPE IV; ENDOTHELIN-1; EXTRACELLULAR MATRIX; FIBRONECTINS; MATRIX METALLOPROTEINASE 2; MESANGIAL CELLS; RATS; RECEPTORS, ENDOTHELIN; RECEPTORS, VASOPRESSIN; VASOCONSTRICTOR AGENTS;

EID: 41749094708     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2007.04852.x     Document Type: Article

References (42)

1. Mauer SM, Steffes MW, Ellis EN, Sutherland DER, Brown DM, Goetz FC. Structural-functional relationships in diabetic nephropathy. J. Clin. Invest. 1984 74 : 1143 55.
2. Striker LJ, Doi T, Elliot S, Striker GE. The contribution of glomerular mesangial cells to progressive glomerulosclerosis. Semin. Nephrol. 1989 9 : 318 28.
3. Kashgarian M. Mesangium and glomerular disease. Lab. Invest. 1988 52 : 569 71.
4. Foidart JB, Dubois CH, Foidart JM, Duchenne CA, Mahieu JP. Tissue culture of normal rat glomeruli: Basement membrane biosynthesis by homogeneous epithelial and mesangial cells lines. Int. Biochem. 1980 12 : 197 202.
5. Foidart JM, Foidart JB, Mahieu PR. Synthesis of collagen and fibronectin by glomerular cells in culture. Renal Physiol. 1980 3 : 183 90.
6. Timpl R. Recent advances in the biochemistry of glomerular basement membrane. Kidney Int. 1986 30 : 293 8.
7. Raugi GJ, Lovett DH. Thrombospondin secretion by cultured human glomerular mesangial cells. Am. J. Pathol. 1987 129 : 364 72.
8. Ganz MB, Pekar SK, Perfetto MC, Sterzel RB. Arginine vasopressin promotes growth of rat glomerular mesangial cells in culture. Am. J. Physiol. 1988 255 : F898 906.
9. Tahara A, Tomura Y, Wada K et al. Effect of YM087, a potent nonpeptide vasopressin antagonist, on vasopressin-induced hyperplasia and hypertrophy of cultured vascular smooth-muscle cells. J. Cardiovasc. Pharmacol. 1997 30 : 759 66.
10. 1A receptor-selective antagonist, on rat mesangial cell hyperplasia and hypertrophy. Vasc. Pharmacol. 2007 46 : 463 9.
11. Schoulze-Lohoff E, Kohler M, Fees H, Reindl N, Sterzel RB. Divergent effects of arginine vasopressin and angiotensin II on proliferation and expression of the immediate early genes c-fos, c-jun and Egr-1 in cultured rat glomerular mesangial cells. J. Hypertens. 1993 11 : 127 34.
12. Mene P, Simonson MS, Dunn MJ. Physiology of the mesangial cells. Physiol. Rev. 1989 69 : 1347 424.
13. 1A receptor-selective antagonist. Vasc. Pharmacol. 2005 42 : 47 55.
14. 2 receptor antagonist. J. Clin. Invest. 1996 98 : 2729 38.
15. A receptor antagonist. Eur. J. Pharmacol. 2003 478 : 61 71.
16. Ishikawa K, Ihara M, Noguchi K et al. Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788. Proc. Natl Acad. Sci. USA 1994 91 : 4892 6.
17. Kohno M, Horio T, Ikeda M et al. Angiotensin II stimulates endothelin-1 secretion in cultured rat mesangial cells. Kidney Int. 1992 42 : 860 6.
18. Rennard SI, Berg R, Martin GR, Foidart JM, Gehron RP. Enzyme-linked immunoassay (ELISA) for connective tissue components. Anal. Biochem. 1980 104 : 205 14.
19. Becker J, Schuppan D, Benzian H et al. Immunohistochemical distribution of collagen type IV, V, and VI and of procollagen type I and III in human alveolar bone and dentine. J. Histochem. Cytochem. 1986 34 : 1417 29.
20. Moshage H, Casini A, Lieber CS. Acetaldehyde selectively stimulates collagen production in cultured rat liver fat-storing cells but not in hepatocytes. Hematology 1990 12 : 511 18.
21. Striker LJ, Peten EP, Elliot SJ, Doi T, Striker GE. Mesangial cell turnover: Effect of heparin and peptide growth factors. Lab. Invest. 1991 64 : 446 56.
22. Border WA, Okuda S, Nakamura T. Extracellular matrix and glomerular disease. Semin. Nephrol. 1989 9 : 307 17.
23. Schor N, Ichikawa I, Brenner BM. Mechanisms of action of various hormones and vasoactive substances on glomerular ultrafiltration in the rat. Kidney Int. 1981 20 : 442 51.
24. Schondorff D. The glomerular mesangial cell: An expanding role for a specialized pericyte. FASEB J. 1987 1 : 272 81.
25. Ausiello DA, Kreisberg JI, Roy C, Karnovsky MJ. Contraction of cultured rat glomerular cells of apparent mesangial origin after stimulation with angiotensin II and arginine vasopressin. J. Clin. Invest. 1980 65 : 754 60.
26. Ikoma M, Kawamura T, Kakinuma Y, Fogo A, Ichikawa I. Cause of variable therapeutic efficiency of angiotensin converting enzyme inhibitor on glomerular lesions. Kidney Int. 1991 40 : 195 202.
27. Edido J. Vasoactive hormones and renal sclerosis. Kidney Int. 1996 49 : 578 97.
28. Wolf G, Haberstroh U, Neilson EG. Angiotensin II stimulates the proliferation and biosynthesis of type I collagen in cultured murine mesangial cells. Am. J. Pathol. 1992 140 : 95 107.
29. Gomez-Garre D, Ruiz-Ortega M, Ortego M et al. Effects and interactions of endothelin-1 and angiotensin II on matrix protein expression and synthesis and mesangial cell growth. Hypertension 1996 27 : 885 92.
30. Remuzzi A, Malanchini B, Battaglia C, Bertani T, Remuzzi G. Comparison of the effects of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade on the evolution of spontaneous glomerular injury in male MWF/Ztm rats. Exp. Nephrol. 1996 4 : 19 25.
31. Sorokin A, Kohan DE. Physiology and pathophysiology of endothelin-1 in renal mesangium. Am. J. Physiol. Renal Physiol. 2003 285 : F579 89.
32. B receptor antagonist ameliorates proteinuria and glomerular lesions in rats with proliferative nephritis. Kidney Int. 1996 50 : 962 72.
33. Benigni A, Zoja C, Corna D et al. A specific endothelin subtype A receptor antagonist protects against injury in renal disease progression. Kidney Int. 1993 44 : 440 4.
34. Tabuchi Y, Nakamura M, Rakugi H et al. Endothelin enhances adrenergic vasoconstriction in perfused rat mesenteric arteries. Biochem. Biophys. Res. Commun. 1989 159 : 1304 8.
35. Yang Z, Richard V, von Segesser L et al. Threshold concentrations of endothelin-1 potentiate contractions to norepinephrine and serotonin in human arteries: A new mechanism of vasospasm? Circulation 1990 82 : 188 95.
36. Weissberg PL, Witcell C, Davenport AP et al. The endothelin peptides, ET-1, ET-2, ET-3 and sarafotoxin S6b, are co-mitogenic with platelet-derived growth factor for vascular smooth muscle cells. Atherosclerosis 1990 85 : 257 62.
37. Gibbons GH, Pratt RE, Dzau VJ. Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II. J. Clin. Invest. 1992 90 : 456 61.
38. Kagami S, Border WA, Miller DE, Noble NA. Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells. J. Clin. Invest. 1994 93 : 2431 7.
39. Border WA, Ruoslahti E. Transforming growth factor-beta in disease: The dark side of tissue repair. J. Clin. Invest. 1992 90 : 1 7.
40. Ruiz-Ortega M, Gonzalez S, Seron D et al. ACE inhibition reduces proteinuria, glomerular lesions and extracellular matrix production in a normotensive rat model of immune complex nephritis. Kidney Int. 1995 48 : 1778 91.
41. Saltis J, Agrotis A, Bobik A. Transforming growth factor-beta 1 enhances the proliferative effects of epidermal growth factor on vascular smooth muscle from the spontaneously hypertensive rat. J. Hypertens. 1991 9 (Suppl S184 5.
42. Kaneto H, Morrissey J, McCracken R, Reyes A, Klahr S. Enalapril reduces collagen type IV synthesis and expansion of the interstitium in the obstructed rat kidney. Kidney Int. 1994 45 : 1637 47.